Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 57 entries
Sorted by: Best Match Show Resources per page
Serum creatine phosphokinase as predictor of intermediate syndrome in organophosphorus poisoning.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

Kumar GC, Bhuvana K, Venkatarathnamma PN, Sarala N.
PMID: 26180430
Indian J Crit Care Med. 2015 Jul;19(7):384-7. doi: 10.4103/0972-5229.160274.

BACKGROUND: Organophosphorus (OP) compounds are commonly used pesticides. In OP poisoning, intermediate syndrome (IMS) manifests between the end of the acute cholinergic crisis and delayed neuropathy. Respiratory paralysis in IMS, if identified early can reduce the need for ventilator...

Cite
Kumar GC, Bhuvana K, Venkatarathnamma PN, et al. Serum creatine phosphokinase as predictor of intermediate syndrome in organophosphorus poisoning. Indian J Crit Care Med. 2015;19(7):384-7doi: 10.4103/0972-5229.160274.
Kumar, G. C., Bhuvana, K., Venkatarathnamma, P. N., & Sarala, N. (2015). Serum creatine phosphokinase as predictor of intermediate syndrome in organophosphorus poisoning. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 19(7), 384-7. https://doi.org/10.4103/0972-5229.160274
Kumar, G Chetan, et al. "Serum creatine phosphokinase as predictor of intermediate syndrome in organophosphorus poisoning." Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine vol. 19,7 (2015): 384-7. doi: https://doi.org/10.4103/0972-5229.160274
Kumar GC, Bhuvana K, Venkatarathnamma PN, Sarala N. Serum creatine phosphokinase as predictor of intermediate syndrome in organophosphorus poisoning. Indian J Crit Care Med. 2015 Jul;19(7):384-7. doi: 10.4103/0972-5229.160274. PMID: 26180430; PMCID: PMC4502490.
Copy Download .nbib Format: NLM
In vivo effect of aflatoxin B(1), on protein synthesis in rat liver.

FEBS letters

Sarasin A, Moulé Y, Darracq N.
PMID: 11946945
FEBS Lett. 1973 Feb 01;29(3):329-332. doi: 10.1016/0014-5793(73)80051-1.

No abstract available.

Cite
Sarasin A, Moulé Y, Darracq N. In vivo effect of aflatoxin B(1), on protein synthesis in rat liver. FEBS Lett. 1973;29(3):329-332doi: 10.1016/0014-5793(73)80051-1.
Sarasin, A., Moulé, Y., & Darracq, N. (1973). In vivo effect of aflatoxin B(1), on protein synthesis in rat liver. FEBS letters, 29(3), 329-332. https://doi.org/10.1016/0014-5793(73)80051-1
Sarasin, A, et al. "In vivo effect of aflatoxin B(1), on protein synthesis in rat liver." FEBS letters vol. 29,3 (1973): 329-332. doi: https://doi.org/10.1016/0014-5793(73)80051-1
Sarasin A, Moulé Y, Darracq N. In vivo effect of aflatoxin B(1), on protein synthesis in rat liver. FEBS Lett. 1973 Feb 01;29(3):329-332. doi: 10.1016/0014-5793(73)80051-1. PMID: 11946945.
Copy Download .nbib Format: NLM
Léon Babaiantz.

Radiologia clinica

SARASIN R, SCHINZ HR, ZDANSKY E, ZUPPINGER A.
PMID: 13453695
Radiol Clin. 1957 May;26(3):179-81.

No abstract available.

Cite
SARASIN R, SCHINZ HR, ZDANSKY E, et al. Léon Babaiantz. Léon Babaiantz. Radiol Clin. 1957;26(3):179-81
SARASIN, R., SCHINZ, H. R., ZDANSKY, E., & ZUPPINGER, A. (1957). Léon Babaiantz. Léon Babaiantz. Radiologia clinica, 26(3), 179-81.
SARASIN, R, et al. "Léon Babaiantz." Léon Babaiantz. Radiologia clinica vol. 26,3 (1957): 179-81.
SARASIN R, SCHINZ HR, ZDANSKY E, ZUPPINGER A. Léon Babaiantz. Léon Babaiantz. Radiol Clin. 1957 May;26(3):179-81. German. PMID: 13453695.
Copy Download .nbib Format: NLM
Angiotensin II Receptor Regulates Ionic Currents in Guinea Pig Ventricular Myocytes.

Journal of cardiovascular pharmacology and therapeutics

Yang Xj, Jiang Wp.
PMID: 10684475
J Cardiovasc Pharmacol Ther. 1998 Jan;3(1):1-10. doi: 10.1177/107424849800300101.

BACKGROUND: Previous studies have shown that angiotensin II (Ang II) receptors are preset in a wide variety of target tissues and that Ang II regulates the target tissue functions through Ang II receptors. However, the action of Ang II...

Cite
Yang Xj, Jiang Wp. Angiotensin II Receptor Regulates Ionic Currents in Guinea Pig Ventricular Myocytes. J Cardiovasc Pharmacol Ther. 1998;3(1):1-10doi: 10.1177/107424849800300101.
Yang, X. j., & Jiang, W. p. (1998). Angiotensin II Receptor Regulates Ionic Currents in Guinea Pig Ventricular Myocytes. Journal of cardiovascular pharmacology and therapeutics, 3(1), 1-10. https://doi.org/10.1177/107424849800300101
Yang, and Jiang. "Angiotensin II Receptor Regulates Ionic Currents in Guinea Pig Ventricular Myocytes." Journal of cardiovascular pharmacology and therapeutics vol. 3,1 (1998): 1-10. doi: https://doi.org/10.1177/107424849800300101
Yang Xj, Jiang Wp. Angiotensin II Receptor Regulates Ionic Currents in Guinea Pig Ventricular Myocytes. J Cardiovasc Pharmacol Ther. 1998 Jan;3(1):1-10. doi: 10.1177/107424849800300101. PMID: 10684475.
Copy Download .nbib Format: NLM
[Therapy and prognosis of Hodgkin's disease; cases in Zurich 1922-50].

Oncologia

HOHL K, SARASIN P, BESSLER W.
PMID: 14853449
Oncologia. 1951;4(1):1-20.

No abstract available.

Cite
HOHL K, SARASIN P, BESSLER W. Therapie und Prognose der Lymphogranulomatose; Zürcher Erfahrungen von 1922-1950. [Therapy and prognosis of Hodgkin's disease; cases in Zurich 1922-50]. Oncologia. 1951;4(1):1-20
HOHL, K., SARASIN, P., & BESSLER, W. (1951). Therapie und Prognose der Lymphogranulomatose; Zürcher Erfahrungen von 1922-1950. [Therapy and prognosis of Hodgkin's disease; cases in Zurich 1922-50]. Oncologia, 4(1), 1-20.
HOHL, K, et al. "Therapie und Prognose der Lymphogranulomatose; Zürcher Erfahrungen von 1922-1950." [Therapy and prognosis of Hodgkin's disease; cases in Zurich 1922-50]. Oncologia vol. 4,1 (1951): 1-20.
HOHL K, SARASIN P, BESSLER W. Therapie und Prognose der Lymphogranulomatose; Zürcher Erfahrungen von 1922-1950. [Therapy and prognosis of Hodgkin's disease; cases in Zurich 1922-50]. Oncologia. 1951;4(1):1-20. Undetermined. PMID: 14853449.
Copy Download .nbib Format: NLM
[Possibilities in combining chemotherapy with radiotherapy].

Radiologia clinica

SARASIN R, DUBOIS-FERRIERE H.
PMID: 14875943
Radiol Clin. 1951 Jul;20(4):255-9.

No abstract available.

Cite
SARASIN R, DUBOIS-FERRIERE H. Possibilités de combinaisons de chimiothérapie et de radiothérapie. [Possibilities in combining chemotherapy with radiotherapy]. Radiol Clin. 1951;20(4):255-9
SARASIN, R., & DUBOIS-FERRIERE, H. (1951). Possibilités de combinaisons de chimiothérapie et de radiothérapie. [Possibilities in combining chemotherapy with radiotherapy]. Radiologia clinica, 20(4), 255-9.
SARASIN, R, and DUBOIS-FERRIERE, H. "Possibilités de combinaisons de chimiothérapie et de radiothérapie." [Possibilities in combining chemotherapy with radiotherapy]. Radiologia clinica vol. 20,4 (1951): 255-9.
SARASIN R, DUBOIS-FERRIERE H. Possibilités de combinaisons de chimiothérapie et de radiothérapie. [Possibilities in combining chemotherapy with radiotherapy]. Radiol Clin. 1951 Jul;20(4):255-9. Undetermined. PMID: 14875943.
Copy Download .nbib Format: NLM
The brain Renin-Angiotensin system and the regulation of prolactin secretion in female rats: influence of ovarian hormones.

Journal of neuroendocrinology

Myers LS, Steele MK.
PMID: 19210444
J Neuroendocrinol. 1989 Aug 01;1(4):299-303. doi: 10.1111/j.1365-2826.1989.tb00119.x.

Abstract This study was designed to investigate the effects of exogenous and endogenous angiotensin II (All) on prolactin release in ovariectomized rats, with and without estrogen and progesterone pretreatment. In the first series of experiments, All or vehicle was...

Cite
Myers LS, Steele MK. The brain Renin-Angiotensin system and the regulation of prolactin secretion in female rats: influence of ovarian hormones. J Neuroendocrinol. 1989;1(4):299-303doi: 10.1111/j.1365-2826.1989.tb00119.x.
Myers, L. S., & Steele, M. K. (1989). The brain Renin-Angiotensin system and the regulation of prolactin secretion in female rats: influence of ovarian hormones. Journal of neuroendocrinology, 1(4), 299-303. https://doi.org/10.1111/j.1365-2826.1989.tb00119.x
Myers, L S, and Steele, M K. "The brain Renin-Angiotensin system and the regulation of prolactin secretion in female rats: influence of ovarian hormones." Journal of neuroendocrinology vol. 1,4 (1989): 299-303. doi: https://doi.org/10.1111/j.1365-2826.1989.tb00119.x
Myers LS, Steele MK. The brain Renin-Angiotensin system and the regulation of prolactin secretion in female rats: influence of ovarian hormones. J Neuroendocrinol. 1989 Aug 01;1(4):299-303. doi: 10.1111/j.1365-2826.1989.tb00119.x. PMID: 19210444.
Copy Download .nbib Format: NLM
Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels.

Journal of pharmacology & pharmacotherapeutics

Bengalorkar GM, Sarala N, Venkatrathnamma PN, Kumar TN.
PMID: 22025855
J Pharmacol Pharmacother. 2011 Oct;2(4):266-9. doi: 10.4103/0976-500X.85956.

INTRODUCTION: To study the effects of heparin and low-molecular weight heparin (LMWH) on potassium and sodium levels in patients with cardiovascular diseases (CVDs) and stroke.MATERIALS AND METHODS: Sixty patients were recruited with 30 patients each receiving heparin and enoxaparin....

Cite
Bengalorkar GM, Sarala N, Venkatrathnamma PN, et al. Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels. J Pharmacol Pharmacother. 2011;2(4):266-9doi: 10.4103/0976-500X.85956.
Bengalorkar, G. M., Sarala, N., Venkatrathnamma, P. N., & Kumar, T. N. (2011). Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels. Journal of pharmacology & pharmacotherapeutics, 2(4), 266-9. https://doi.org/10.4103/0976-500X.85956
Bengalorkar, Girish M, et al. "Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels." Journal of pharmacology & pharmacotherapeutics vol. 2,4 (2011): 266-9. doi: https://doi.org/10.4103/0976-500X.85956
Bengalorkar GM, Sarala N, Venkatrathnamma PN, Kumar TN. Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels. J Pharmacol Pharmacother. 2011 Oct;2(4):266-9. doi: 10.4103/0976-500X.85956. PMID: 22025855; PMCID: PMC3198522.
Copy Download .nbib Format: NLM
Antiurolithiatic Effects of Solanum xanthocarpum Fruit Extract on Ethylene-Glycol-Induced Nephrolithiasis in Rats.

Journal of young pharmacists : JYP

Patel P, Patel M, Saralai M, Gandhi T.
PMID: 23112535
J Young Pharm. 2012 Jul;4(3):164-70. doi: 10.4103/0975-1483.100022.

This study was designed to evaluate the effects of Solanum xanthocarpum fruit extract in ethylene-glycol-induced urolithiasis in the male Wistar rats. Nephrolithiasis was induced in male Wistar rats by adding ethylene glycol (0.75%) in drinking water for 28 days....

Cite
Patel P, Patel M, Saralai M, et al. Antiurolithiatic Effects of Solanum xanthocarpum Fruit Extract on Ethylene-Glycol-Induced Nephrolithiasis in Rats. J Young Pharm. 2012;4(3):164-70doi: 10.4103/0975-1483.100022.
Patel, P., Patel, M., Saralai, M., & Gandhi, T. (2012). Antiurolithiatic Effects of Solanum xanthocarpum Fruit Extract on Ethylene-Glycol-Induced Nephrolithiasis in Rats. Journal of young pharmacists : JYP, 4(3), 164-70. https://doi.org/10.4103/0975-1483.100022
Patel, Pk, et al. "Antiurolithiatic Effects of Solanum xanthocarpum Fruit Extract on Ethylene-Glycol-Induced Nephrolithiasis in Rats." Journal of young pharmacists : JYP vol. 4,3 (2012): 164-70. doi: https://doi.org/10.4103/0975-1483.100022
Patel P, Patel M, Saralai M, Gandhi T. Antiurolithiatic Effects of Solanum xanthocarpum Fruit Extract on Ethylene-Glycol-Induced Nephrolithiasis in Rats. J Young Pharm. 2012 Jul;4(3):164-70. doi: 10.4103/0975-1483.100022. PMID: 23112535; PMCID: PMC3483526.
Copy Download .nbib Format: NLM
Saralasin and Sarile Are AT2 Receptor Agonists.

ACS medicinal chemistry letters

Guimond MO, Hallberg M, Gallo-Payet N, Wallinder C.
PMID: 25313325
ACS Med Chem Lett. 2014 Aug 18;5(10):1129-32. doi: 10.1021/ml500278g. eCollection 2014 Oct 09.

Saralasin and sarile, extensively studied over the past 40 years as angiotensin II (Ang II) receptor blockers, induce neurite outgrowth in a NG108-15 cell assay to a similar extent as the endogenous Ang II. In their undifferentiated state, these...

Cite
Guimond MO, Hallberg M, Gallo-Payet N, et al. Saralasin and Sarile Are AT2 Receptor Agonists. ACS Med Chem Lett. 2014;5(10):1129-32doi: 10.1021/ml500278g.
Guimond, M. O., Hallberg, M., Gallo-Payet, N., & Wallinder, C. (2014). Saralasin and Sarile Are AT2 Receptor Agonists. ACS medicinal chemistry letters, 5(10), 1129-32. https://doi.org/10.1021/ml500278g
Guimond, Marie-Odile, et al. "Saralasin and Sarile Are AT2 Receptor Agonists." ACS medicinal chemistry letters vol. 5,10 (2014): 1129-32. doi: https://doi.org/10.1021/ml500278g
Guimond MO, Hallberg M, Gallo-Payet N, Wallinder C. Saralasin and Sarile Are AT2 Receptor Agonists. ACS Med Chem Lett. 2014 Aug 18;5(10):1129-32. doi: 10.1021/ml500278g. eCollection 2014 Oct 09. PMID: 25313325; PMCID: PMC4190624.
Copy Download .nbib Format: NLM
COVID-19 Related Fears of Patients Admitted to a Psychiatric Emergency Department during and Post-Lockdown in Switzerland: Preliminary Findings to Look Ahead for Tailored Preventive Mental Health Strategies.

Medicina (Kaunas, Lithuania)

Costanza A, Macheret L, Folliet A, Amerio A, Aguglia A, Serafini G, Prada P, Bondolfi G, Sarasin F, Ambrosetti J.
PMID: 34946305
Medicina (Kaunas). 2021 Dec 13;57(12). doi: 10.3390/medicina57121360.

No abstract available.

Cite
Costanza A, Macheret L, Folliet A, et al. COVID-19 Related Fears of Patients Admitted to a Psychiatric Emergency Department during and Post-Lockdown in Switzerland: Preliminary Findings to Look Ahead for Tailored Preventive Mental Health Strategies. Medicina (Kaunas). 2021;57(12)doi: 10.3390/medicina57121360.
Costanza, A., Macheret, L., Folliet, A., Amerio, A., Aguglia, A., Serafini, G., Prada, P., Bondolfi, G., Sarasin, F., & Ambrosetti, J. (2021). COVID-19 Related Fears of Patients Admitted to a Psychiatric Emergency Department during and Post-Lockdown in Switzerland: Preliminary Findings to Look Ahead for Tailored Preventive Mental Health Strategies. Medicina (Kaunas, Lithuania), 57(12), . https://doi.org/10.3390/medicina57121360
Costanza, Alessandra, et al. "COVID-19 Related Fears of Patients Admitted to a Psychiatric Emergency Department during and Post-Lockdown in Switzerland: Preliminary Findings to Look Ahead for Tailored Preventive Mental Health Strategies." Medicina (Kaunas, Lithuania) vol. 57,12 (2021). doi: https://doi.org/10.3390/medicina57121360
Costanza A, Macheret L, Folliet A, Amerio A, Aguglia A, Serafini G, Prada P, Bondolfi G, Sarasin F, Ambrosetti J. COVID-19 Related Fears of Patients Admitted to a Psychiatric Emergency Department during and Post-Lockdown in Switzerland: Preliminary Findings to Look Ahead for Tailored Preventive Mental Health Strategies. Medicina (Kaunas). 2021 Dec 13;57(12). doi: 10.3390/medicina57121360. PMID: 34946305.
Copy Download .nbib Format: NLM
Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver.

European journal of immunology

Di Censo C, Marotel M, Mattiola I, Müller L, Scarno G, Pietropaolo G, Peruzzi G, Laffranchi M, Mazej J, Hasim MS, Asif S, Russo E, Tomaipitinca L, Stabile H, Lee SH, Vian L, Gadina M, Gismondi A, Shih HY, Mikami Y, Capuano C, Bernardini G, Bonelli M, Sozzani S, Diefenbach A, Ardolino M, Santoni A, Sciumè G.
PMID: 34347289
Eur J Immunol. 2021 Nov;51(11):2568-2575. doi: 10.1002/eji.202149209. Epub 2021 Aug 19.

Type 1 innate lymphoid cells (ILC1) are tissue-resident lymphocytes that provide early protection against bacterial and viral infections. Discrete transcriptional states of ILC1 have been identified in homeostatic and pathological contexts. However, whether these states delineate ILC1 with different...

Cite
Di Censo C, Marotel M, Mattiola I, et al. Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver. Eur J Immunol. 2021;51(11):2568-2575doi: 10.1002/eji.202149209.
Di Censo, C., Marotel, M., Mattiola, I., Müller, L., Scarno, G., Pietropaolo, G., Peruzzi, G., Laffranchi, M., Mazej, J., Hasim, M. S., Asif, S., Russo, E., Tomaipitinca, L., Stabile, H., Lee, S. H., Vian, L., Gadina, M., Gismondi, A., Shih, H. Y., Mikami, Y., Capuano, C., Bernardini, G., Bonelli, M., Sozzani, S., Diefenbach, A., Ardolino, M., Santoni, A., & Sciumè, G. (2021). Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver. European journal of immunology, 51(11), 2568-2575. https://doi.org/10.1002/eji.202149209
Di Censo, Chiara, et al. "Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver." European journal of immunology vol. 51,11 (2021): 2568-2575. doi: https://doi.org/10.1002/eji.202149209
Di Censo C, Marotel M, Mattiola I, Müller L, Scarno G, Pietropaolo G, Peruzzi G, Laffranchi M, Mazej J, Hasim MS, Asif S, Russo E, Tomaipitinca L, Stabile H, Lee SH, Vian L, Gadina M, Gismondi A, Shih HY, Mikami Y, Capuano C, Bernardini G, Bonelli M, Sozzani S, Diefenbach A, Ardolino M, Santoni A, Sciumè G. Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver. Eur J Immunol. 2021 Nov;51(11):2568-2575. doi: 10.1002/eji.202149209. Epub 2021 Aug 19. PMID: 34347289.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 57 entries